Nebenwirkungen · Capecitabine Teva
Capecitabine Teva 150 mg film-coated tablets Capecitabine Teva 500 mg film-coated tablets · Abschnitt 4.8 · PDF-Seite 17–18
HOS-215432 · Präparat HOS-155434
17 Body System Very Common Common Rare/Very Rare (Post-Marketing All grades All grades Experience) Musculoskeletal and Myalgia, Arthralgia, Pain in jaw, Muscle connective tissue Pain in extremity spasms, Trismus, disorders Muscular weakness Renal and urinary - Haematuria, Acute renal failure disorders Proteinuria, Creatinine secondary to renal clearance dehydration (rare) decreased, Dysuria General disorders and Pyrexia, Weakness, Mucosal inflammation, + administration site Lethargy, Temperature Pain in limb, Pain, conditions intolerance Chills, Chest pain, Influenza-like illness, + Fever, Infusion related reaction, Injection site reaction, Infusion site pain, Injection site pain Injury, poisoning and - Contusion procedural complications + For each term, the frequency count was based on ADRs of all grades. For terms marked with a “+”, the frequency count was based on grade 3-4 ADRs. ADRs are added according to the highest incidence seen in any of the major combination trials.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-07-11T15:40:00Z · SHA-256 360b33238effee7033c9ecfa3731a36e172b67d4837e971f09a6e80d5cda73df · Passage 324130b378c8cb9c5e4ed8a1ccaad4913f4725272ecea1dba0d940c74a3c4f07 · Zeichen 21527–23547 im Abschnitt